Economy & Markets
5 min read
Philips Recognized as Clarivate Top 100 Global Innovator for 13th Consecutive Year
Philips
January 21, 2026•1 day ago

AI-Generated SummaryAuto-generated
Philips has been named a Clarivate Top 100 Global Innovator for the thirteenth consecutive year, recognizing its sustained commitment to innovation. The company invests over €1.7 billion annually in R&D, focusing on AI-enabled technologies in healthcare and consumer health. Notable innovations include spectral CT, helium-free MRI technology, point-of-care ultrasound, and advanced personal care devices.
Philips’ recognition reflects its long-term commitment to innovation, supported by more than EUR 1.7 billion in annual R&D investment – approximately 9% of sales and among the highest levels in the industry. Across professional healthcare and consumer health, Philips is applying AI-enabled technologies, advanced imaging, and connected platforms to support more precise diagnosis, simplify workflows, and empower people to proactively manage their health and well-being. Examples of Philips' latest innovations include:
Philips Verida, the world’s first detector-based spectral CT powered by integrating AI across the imaging chain, from acquisition to reconstruction.
Helium-free [1] MRI magnet technology, led by Philips since 2018, with more than 2,000 installations worldwide and six million liters of liquid helium saved to date, helping hospitals eliminate helium refills and vent pipes.
Philips Flash 5100 Point-of-Care Ultrasound, combining advanced imaging clarity and intuitive workflow to support rapid, confident decision-making in frontline clinical settings.
A next-generation web-based diagnostic viewer that transforms how radiologists access and interpret medical images, enabling clinicians to work smarter, faster, and more collaboratively.
AI-enabled personal care innovations, including the Philips i9000 Shaver Series and advanced hair-removal solutions, deliver more personalized and intuitive self-care experiences for consumers.
Rate this article
Login to rate this article
Comments
Please login to comment
No comments yet. Be the first to comment!
